Clinical Study of Qi-Shao-Tong-Mai-An-Shen Decoction (QSTMASD) Regimen for Coronary Heart Disease Syndrome of Qi Deficiency and Blood Stasis Patients with Anxiety and/or Depressio
- Conditions
- Coronary heart disease with anxiety and/or depression
- Registration Number
- ITMCTR2200006722
- Lead Sponsor
- China-Japan Friendship Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
a)Confirmed to the diagnostic criteria of SCAD;
b)Confirmed to TCM syndrome of Qi deficiency and blood stasis;
c)Confirmed to the diagnostic criteria of mild and moderate anxiety and/or depression using psychological evaluation scales and the early warning system of China-Japan Friendship Hospital;
d)Age 18-65 years old;
e)Accept and cooperate with the trial scheme
f)Volunteer to participate in this study and sign the informed consent forms.
People Who meet the above requirements were included in this study.
a)Patients who are receiving anxiolytics, antidepressants or drugs for other mental disorders within one month;
b)Combined with severe cardiac insufficiency, such as Killip grade II and above; NYHA grade III and above;
c)Combined with other serious diseases, such as severe liver and kidney dysfunction (ALT > 3 × upper limits of normal, SCR > 221 µ mol/L); Severe consumption state or malignant tumor;
d)Pregnant or lactating women, or those with pregnancy plans;
e)Suspicious or definite allergy to Traditional Chinese Medicine or proprietary Chinese medicine;
f)Those who use with similar efficacy to the Traditional Chinese Medicine within 2 weeks;
g)Those who are participating in other clinical studies now or within one month.
If any of the above conditions are met, it will be excluded.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method